PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $133,000 | -60.7% | 18,012 | -63.8% | 0.00% | – |
| Q2 2017 | $338,000 | -27.9% | 49,732 | 0.0% | 0.00% | -100.0% |
| Q1 2017 | $469,000 | +171.1% | 49,732 | +76.7% | 0.00% | – |
| Q4 2015 | $173,000 | -64.0% | 28,144 | -66.4% | 0.00% | -100.0% |
| Q3 2015 | $480,000 | -35.3% | 83,877 | -15.6% | 0.00% | 0.0% |
| Q2 2015 | $742,000 | +97.3% | 99,410 | +58.0% | 0.00% | 0.0% |
| Q1 2015 | $376,000 | +43.5% | 62,900 | +81.8% | 0.00% | 0.0% |
| Q4 2014 | $262,000 | +235.9% | 34,600 | +91.2% | 0.00% | – |
| Q2 2014 | $78,000 | -68.5% | 18,100 | -70.2% | 0.00% | -100.0% |
| Q1 2014 | $248,000 | -19.0% | 60,700 | +5.6% | 0.00% | 0.0% |
| Q4 2013 | $306,000 | -72.6% | 57,500 | -77.0% | 0.00% | -75.0% |
| Q2 2013 | $1,115,000 | +332.2% | 250,000 | +188.3% | 0.00% | +300.0% |
| Q4 2012 | $258,000 | – | 86,703 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 6,158,000 | $38,611,000 | 2.32% |
| ARDSLEY ADVISORY PARTNERS LP | 2,045,000 | $12,822,000 | 1.73% |
| RA Capital Management | 3,030,303 | $19,000,000 | 1.02% |
| Phocas Financial Corp. | 1,736,386 | $10,887,000 | 0.95% |
| ARDSLEY ADVISORY PARTNERS LP | 500,000 | $3,135,000 | 0.42% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,345,260 | $8,435,000 | 0.30% |
| BKS ADVISORS, LLC | 115,115 | $721,000 | 0.26% |
| PINNACLE ASSOCIATES LTD | 1,530,657 | $9,597,000 | 0.20% |
| CARILLON TOWER ADVISERS, INC. | 3,948,024 | $24,745,000 | 0.18% |
| EAGLE ASSET MANAGEMENT INC | 4,444,673 | $27,868,000 | 0.14% |